Orris

Explain in detail about congestive heart faliure

Reading File
Now let me search the medical library for comprehensive content on congestive heart failure, running parallel searches.
Finding Sources
Finding Sources
Searching Images

congestive heart failure pathophysiology diagram

Excellent results. Now let me read the most authoritative sources in parallel - Braunwald's Heart Disease, Robbins Pathology, and Katzung's Pharmacology for pathophysiology, plus the clinical content.
Reading File
Reading File
Reading File
Good content so far. Let me now read more from Robbins Pathology on progression to heart failure, and search for clinical features, classification, and management.
Reading File
Finding Sources
Reading File
Excellent material. Let me now get the right-sided failure content, NYHA classification, and treatment sections.
Reading File
Finding Sources
Finding Sources
Let me get the pharmacology treatment section from Katzung and search for images and NYHA classification.
Reading File
Finding Sources
Searching Images

heart failure chest X-ray pulmonary edema

This anterior-posterior (AP) chest X-ray illustrates classic radiological findings of acute congestive heart failure. The primary finding is significant cardiomegaly, with the cardiac silhouette appearing enlarged and globular, occupying more than 50% of the thoracic diameter. Diffuse, bilateral hazy opacities are present throughout both lung fields, consistent with pulmonary edema. These opacifications are most prominent in the perihilar regions and lung bases, obscuring normal pulmonary vasculature and the sharp definition of the diaphragmatic borders. The costophrenic angles appear blunted, suggesting associated pleural effusions. Visible medical hardware includes ECG leads positioned on the chest wall. The image serves as an educational example of how chronic heart failure with reduced ejection fraction manifests as pulmonary venous congestion and interstitial-to-alveolar edema on diagnostic imaging.

This anterior-posterior (AP) chest X-ray illustrates classic radiological findings of acute congestive heart failure. The primary finding is significant cardiomegaly, with the cardiac silhouette appearing enlarged and globular, occupying more than 50% of the thoracic diameter. Diffuse, bilateral hazy opacities are present throughout both lung fields, consistent with pulmonary edema. These opacifications are most prominent in the perihilar regions and lung bases, obscuring normal pulmonary vasculature and the sharp definition of the diaphragmatic borders. The costophrenic angles appear blunted, suggesting associated pleural effusions. Visible medical hardware includes ECG leads positioned on the chest wall. The image serves as an educational example of how chronic heart failure with reduced ejection fraction manifests as pulmonary venous congestion and interstitial-to-alveolar edema on diagnostic imaging.

Posteroanterior (PA) view chest X-ray demonstrating clinical features of congestive heart failure and pulmonary edema. The image shows significant cardiomegaly with an enlarged cardiac silhouette. There is evidence of pulmonary venous hypertension, specifically characterized by upper lobe diversion where the vascular markings in the upper lobes are more prominent than those in the lower zones. The hilar regions appear congested with increased density and blurring of the hilar shadows. In the lower lung fields, patchy opacities and areas of increased density are visible, consistent with pulmonary consolidation or alveolar edema. The diaphragmatic angles appear somewhat obscured by the parenchymal density changes. This radiographic presentation is typical for decompensated heart failure, illustrating the redistribution of blood flow and fluid accumulation within the pulmonary parenchyma.

Posteroanterior (PA) view chest X-ray demonstrating clinical features of congestive heart failure and pulmonary edema. The image shows significant cardiomegaly with an enlarged cardiac silhouette. There is evidence of pulmonary venous hypertension, specifically characterized by upper lobe diversion where the vascular markings in the upper lobes are more prominent than those in the lower zones. The hilar regions appear congested with increased density and blurring of the hilar shadows. In the lower lung fields, patchy opacities and areas of increased density are visible, consistent with pulmonary consolidation or alveolar edema. The diaphragmatic angles appear somewhat obscured by the parenchymal density changes. This radiographic presentation is typical for decompensated heart failure, illustrating the redistribution of blood flow and fluid accumulation within the pulmonary parenchyma.

This diagnostic image is a posterior-anterior (PA) view chest X-ray demonstrating classic signs of congestive heart failure and acute pulmonary edema. Centrally, there is significant cardiomegaly with an increased cardiothoracic ratio, suggesting left ventricular enlargement. The pulmonary parenchyma shows widespread, bilateral increased opacification and haziness, particularly in the perihilar regions and lower lung zones, consistent with interstitial and alveolar edema. A black arrow in the right medial lung field specifically highlights enlarged, prominent pulmonary arteries and congested vascular markings (cephalization). The costophrenic angles appear partially obscured, which may indicate small pleural effusions. An implanted medical device, consistent with a chemotherapy port (Port-a-Cath), is visible in the right upper thoracic region with its catheter tip terminating in the superior vena cava. This visual evidence supports a clinical diagnosis of decompensated heart failure and pulmonary vascular congestion.

This diagnostic image is a posterior-anterior (PA) view chest X-ray demonstrating classic signs of congestive heart failure and acute pulmonary edema. Centrally, there is significant cardiomegaly with an increased cardiothoracic ratio, suggesting left ventricular enlargement. The pulmonary parenchyma shows widespread, bilateral increased opacification and haziness, particularly in the perihilar regions and lower lung zones, consistent with interstitial and alveolar edema. A black arrow in the right medial lung field specifically highlights enlarged, prominent pulmonary arteries and congested vascular markings (cephalization). The costophrenic angles appear partially obscured, which may indicate small pleural effusions. An implanted medical device, consistent with a chemotherapy port (Port-a-Cath), is visible in the right upper thoracic region with its catheter tip terminating in the superior vena cava. This visual evidence supports a clinical diagnosis of decompensated heart failure and pulmonary vascular congestion.

Now let me get the NYHA/ACC-AHA classification table from Braunwald's and the treatment details.
Reading File
Finding Sources
Searching Images

left ventricular hypertrophy cardiac remodeling heart failure

This diagnostic image is a standard transthoracic apical four-chamber view echocardiogram demonstrating advanced morphological changes secondary to pulmonary hypertension (PH). The visual focus is on the right heart structures, which exhibit significant remodeling due to chronic pressure and volume overload. Key findings include marked right ventricular (RV) hypertrophy, evidenced by thickened myocardial walls, and severe RV dilatation. The RV has lost its typical crescentic shape, appearing more spherical and globular. Furthermore, there is massive dilatation of the right atrium (RA), which appears disproportionately large compared to the left-sided chambers. These features—RV hypertrophy, spherical remodeling, and RA enlargement—are hallmark indicators of right heart failure and increased right ventricular wall stress. The image serves as an educational example of cardiac adaptation to increased pulmonary vascular resistance and chronic right heart afterload.

This diagnostic image is a standard transthoracic apical four-chamber view echocardiogram demonstrating advanced morphological changes secondary to pulmonary hypertension (PH). The visual focus is on the right heart structures, which exhibit significant remodeling due to chronic pressure and volume overload. Key findings include marked right ventricular (RV) hypertrophy, evidenced by thickened myocardial walls, and severe RV dilatation. The RV has lost its typical crescentic shape, appearing more spherical and globular. Furthermore, there is massive dilatation of the right atrium (RA), which appears disproportionately large compared to the left-sided chambers. These features—RV hypertrophy, spherical remodeling, and RA enlargement—are hallmark indicators of right heart failure and increased right ventricular wall stress. The image serves as an educational example of cardiac adaptation to increased pulmonary vascular resistance and chronic right heart afterload.

This clinical imaging figure consists of two side-by-side grayscale echocardiogram still frames focusing on the left heart chambers of a 63-year-old female patient. The diagnostic images illustrate key features of cardiovascular pathology associated with heart failure and atrial fibrillation. Centrally, the left ventricle is visible, showing moderately thickened myocardial walls consistent with left ventricular hypertrophy. The endocardial borders and chamber dimensions are delineated, reflecting decreased left ventricular diastolic function. While valve structures are partially visible, they are not the primary focus of these specific frames. The imaging serves as a clinical demonstration of the structural remodeling and hemodynamic changes seen in chronic cardiac conditions, including atrial fibrillation and congestive heart failure. These visual findings are relevant for medical students and clinicians studying cardiac ultrasound indicators like ejection fraction (LVEF) and ventricular geometry in the context of cardiovascular disease management.

This clinical imaging figure consists of two side-by-side grayscale echocardiogram still frames focusing on the left heart chambers of a 63-year-old female patient. The diagnostic images illustrate key features of cardiovascular pathology associated with heart failure and atrial fibrillation. Centrally, the left ventricle is visible, showing moderately thickened myocardial walls consistent with left ventricular hypertrophy. The endocardial borders and chamber dimensions are delineated, reflecting decreased left ventricular diastolic function. While valve structures are partially visible, they are not the primary focus of these specific frames. The imaging serves as a clinical demonstration of the structural remodeling and hemodynamic changes seen in chronic cardiac conditions, including atrial fibrillation and congestive heart failure. These visual findings are relevant for medical students and clinicians studying cardiac ultrasound indicators like ejection fraction (LVEF) and ventricular geometry in the context of cardiovascular disease management.

This diagnostic image is a transthoracic echocardiogram in a parasternal long-axis view, demonstrating significant structural cardiac abnormalities. The visual highlights include marked ventricular dilation and thickening of the ventricular walls, consistent with ventricular hypertrophy. An annotation in the upper left corner, 'Ao asc 3.4 cm', indicates a measurement of the ascending aorta's diameter. The cardiac chambers appear enlarged, and the myocardium exhibits increased echogenicity. This imaging provides evidence of chronic heart remodeling, often associated with systemic conditions such as systemic lupus erythematosus (SLE) or hypertensive heart disease, resulting in congestive heart failure. The image serves as a clinical example of structural heart changes secondary to long-term inflammatory or hypertensive disease, facilitating the study of cardiomyopathy and aortic root evaluation via ultrasound.

This diagnostic image is a transthoracic echocardiogram in a parasternal long-axis view, demonstrating significant structural cardiac abnormalities. The visual highlights include marked ventricular dilation and thickening of the ventricular walls, consistent with ventricular hypertrophy. An annotation in the upper left corner, 'Ao asc 3.4 cm', indicates a measurement of the ascending aorta's diameter. The cardiac chambers appear enlarged, and the myocardium exhibits increased echogenicity. This imaging provides evidence of chronic heart remodeling, often associated with systemic conditions such as systemic lupus erythematosus (SLE) or hypertensive heart disease, resulting in congestive heart failure. The image serves as a clinical example of structural heart changes secondary to long-term inflammatory or hypertensive disease, facilitating the study of cardiomyopathy and aortic root evaluation via ultrasound.

Let me get the Goldman-Cecil treatment details and also fetch one key image.
Reading File
Loading Image
I now have comprehensive material from multiple authoritative textbooks. Let me compile the full detailed response.

Congestive Heart Failure (CHF) - A Comprehensive Overview

Congestive heart failure (CHF) is a clinical syndrome in which the heart is unable to pump sufficient blood to meet the metabolic demands of the body, or can do so only at the cost of abnormally elevated filling pressures. "Congestive" refers to the resultant fluid backup (congestion) in the pulmonary and/or systemic venous circulation.

1. Definition and Types

CHF is not a single disease but a final common pathway for many cardiac disorders. It is broadly classified as:
By Ventricular Function:
  • Heart Failure with Reduced Ejection Fraction (HFrEF) - systolic dysfunction; EF < 40-45%. Cardiac output is significantly reduced. This is the classic form, seen after myocardial infarction.
  • Heart Failure with Preserved Ejection Fraction (HFpEF) - diastolic dysfunction; EF may be normal (>60%), but stiff, hypertrophied myocardium impairs filling. Cardiac output is reduced despite a normal EF. Drug treatment differs from HFrEF.
  • High-Output Failure - a rare form where even increased cardiac output is insufficient for the body's demands (hyperthyroidism, beriberi, severe anemia, arteriovenous shunts).
By Side:
  • Left-sided CHF - pulmonary congestion predominates
  • Right-sided CHF - systemic venous congestion predominates
  • Biventricular (global) CHF - both sides fail
  • Katzung's Basic and Clinical Pharmacology, 16th Ed.

2. Etiology (Causes)

CategoryExamples
Ischemic Heart DiseaseMyocardial infarction, chronic ischemia (most common cause)
HypertensionChronic pressure overload
Valvular DiseaseAortic stenosis/regurgitation, mitral regurgitation
CardiomyopathyDilated, hypertrophic, restrictive
ArrhythmiasAtrial fibrillation (can cause cardiomyopathy when rate is uncontrolled)
Cor PulmonalePulmonary hypertension, COPD
Metabolic/ToxicThyroid disease, alcohol, chemotherapy (anthracyclines)
Congenital HDVarious structural defects
  • Robbins, Cotran & Kumar Pathologic Basis of Disease

3. Pathophysiology

3a. Cardiac Hypertrophy - The Initial Response

When the heart faces increased work (pressure or volume overload), myocytes enlarge (cellular hypertrophy). The pattern depends on the stimulus:
  • Pressure-overload hypertrophy (e.g., hypertension, aortic stenosis): New sarcomeres are assembled in parallel, expanding cross-sectional area → concentric hypertrophy with thick walls and a small cavity.
  • Volume-overload hypertrophy (e.g., mitral/aortic regurgitation): New sarcomeres are assembled in series → eccentric hypertrophy with dilation. The wall may look normal in thickness despite increased heart weight.
Left ventricular hypertrophy - pressure vs. volume overload. Transverse sections of hearts showing normal (center), pressure-hypertrophied (left - thick walls, small cavity), and hypertrophied-dilated (right - enlarged chamber)
Fig: Left ventricular hypertrophy. Left = pressure hypertrophy (thick walls); Center = normal; Right = hypertrophy with dilation (volume overload or failure). From Robbins Pathology.
Importantly, myocyte hypertrophy is NOT accompanied by a proportional increase in capillary density. This creates a supply-demand mismatch: the thickened wall becomes ischemic, especially in the subendocardium.
  • Robbins, Cotran & Kumar Pathologic Basis of Disease, p. 499-500

3b. Neurohumoral Compensation - The Vicious Cycle

When cardiac output falls, the body activates compensatory mechanisms that are initially helpful but ultimately harmful in the long run:
1. Sympathetic Nervous System Activation
  • Baroreceptor reflex is reset at lower sensitivity in CHF
  • Increased sympathetic outflow → tachycardia, increased contractility, vasoconstriction
  • Vasoconstriction (also driven by angiotensin II and endothelin) increases afterload, which further reduces ejection fraction - a vicious cycle
2. Renin-Angiotensin-Aldosterone System (RAAS)
  • Reduced renal perfusion activates renin release
  • Angiotensin II causes vasoconstriction, promotes norepinephrine release, and stimulates aldosterone
  • Aldosterone → sodium and water retention → increased preload and volume overload
  • Angiotensin II also drives cardiac fibrosis and remodeling
3. Arginine Vasopressin (ADH)
  • Released from the posterior pituitary → free water retention, worsening volume overload
4. Natriuretic Peptides (BNP, ANP)
  • Released from ventricular myocytes under wall stress
  • Counteract the RAAS by promoting natriuresis and vasodilation
  • Clinically used as biomarkers: elevated BNP/NT-proBNP is diagnostic of CHF
  • Katzung's Basic and Clinical Pharmacology, 16th Ed., p. 334-335

3c. Cellular and Molecular Changes

With sustained failure, more damaging cellular events occur:
  • Beta-receptor downregulation: Prolonged sympathetic stimulation causes downregulation of cardiac β1 receptors, reducing the heart's ability to respond to catecholamines
  • Calcium handling abnormalities: SERCA (SR Ca²⁺-ATPase) function is impaired, reducing Ca²⁺ reuptake; RyR channels leak Ca²⁺ from the SR → impaired contraction and relaxation, and arrhythmias
  • Apoptosis: Elevated caspase activity from excessive β-adrenergic stimulation accelerates myocyte death
  • Cardiac Remodeling: Structural changes including dilation, fibrosis, and altered ventricular geometry. Myocytes develop characteristics of fetal myocytes. Connective tissue proliferation stiffens the heart.
  • Mitochondrial dysfunction: Energy production is impaired in the overworked heart
  • Potassium channel alterations: Predispose to life-threatening arrhythmias (a major cause of death in CHF)
  • Katzung's Basic and Clinical Pharmacology, 16th Ed., p. 334-335

4. Classification

ACC/AHA Staging (Braunwald's Heart Disease)

StageDescriptionCorresponds to NYHA
AAt high risk for HF but without structural disease or symptomsNone
BStructural heart disease but without signs/symptomsClass I
CStructural heart disease with prior or current symptomsClass I, II, or III
DRefractory HF requiring specialized interventionsClass IV

NYHA Functional Classification

ClassDescription
INo limitation. Ordinary activity does not cause symptoms
IISlight limitation. Comfortable at rest; ordinary activity causes symptoms
IIIMarked limitation. Comfortable at rest; less-than-ordinary activity causes symptoms
IVSymptoms at rest; unable to carry on any activity without symptoms
  • Braunwald's Heart Disease, A Textbook of Cardiovascular Medicine

5. Clinical Features

Left-Sided Heart Failure (Pulmonary Congestion)

  • Dyspnea on exertion - the cardinal symptom; reflects rising pulmonary venous pressure
  • Orthopnea - dyspnea when lying flat; relieved by sitting up (increased venous return overwhelms failing LV)
  • Paroxysmal Nocturnal Dyspnea (PND) - sudden awakening with breathlessness
  • Cardiac Asthma - bronchospasm from pulmonary edema
  • Cough - especially nocturnal; may produce frothy/pink sputum in acute pulmonary edema
  • Fatigue - reduced cardiac output with poor peripheral perfusion
  • Tachycardia
  • S3 gallop (ventricular filling sound) - indicates volume overload
  • Fine bibasal crackles on auscultation
  • Displaced apex beat (cardiomegaly)
Morphological changes in left-sided CHF:
  • Heart: LV hypertrophy and dilation; secondary LA dilation → atrial fibrillation risk; thrombus formation in atrial appendage
  • Lungs: "Heavy, wet lungs" - perivascular and interstitial edema; alveolar edema; heart failure cells (hemosiderin-laden macrophages in alveoli from extravasated red cells) are a hallmark; pleural effusions (serous transudates)
  • Robbins, Cotran & Kumar Pathologic Basis of Disease, p. 500

Right-Sided Heart Failure (Systemic Venous Congestion)

Most often caused by chronic left-sided failure (most common cause), or by cor pulmonale (lung disease).
  • Peripheral edema - pitting edema of feet, ankles, legs; sacral edema in bedridden patients
  • Anasarca - generalized massive edema
  • Jugular venous distension (JVD)
  • Hepatomegaly - congestive hepatomegaly (tender, pulsatile liver)
  • Ascites - peritoneal fluid accumulation
  • Splenomegaly - with platelet sequestration
  • Nausea/anorexia - bowel wall edema impairs absorption
  • Azotemia - renal congestion
Morphological changes in right-sided CHF:
  • Liver: "Nutmeg liver" - congested red-brown pericentral zones around central veins with normal tan periportal regions; in severe/longstanding cases, cardiac cirrhosis can develop
  • Pleural/Pericardial/Peritoneal spaces: Transudative effusions; ascites
  • Subcutaneous tissues: Dependent pitting edema; anasarca
  • Kidneys: Greater fluid retention and azotemia than in left-sided failure
  • Robbins, Cotran & Kumar Pathologic Basis of Disease, p. 501

6. Investigations

Imaging

Chest X-ray (CXR) - classic features:
  • Cardiomegaly (cardiothoracic ratio > 0.5)
  • Upper lobe blood diversion (cephalization of pulmonary vasculature)
  • Kerley B lines (interstitial edema in interlobular septa)
  • Perihilar "bat-wing" haziness (alveolar edema)
  • Bilateral pleural effusions (blunting of costophrenic angles)
AP chest X-ray showing acute congestive heart failure: cardiomegaly with enlarged globular cardiac silhouette, bilateral perihilar haziness consistent with pulmonary edema, and blunting of costophrenic angles from pleural effusions
PA chest X-ray in congestive heart failure: cardiomegaly, upper lobe diversion, congested hilar shadows, and patchy lower zone opacities consistent with alveolar edema
Echocardiography - the most valuable investigation:
  • Measures ejection fraction (differentiates HFrEF from HFpEF)
  • Assesses wall motion, valve function, chamber dimensions
  • Detects mural thrombosis
ECG - may show LVH, arrhythmias, ST changes, LBBB

Biomarkers

  • BNP / NT-proBNP - released from ventricular myocytes under wall stress; elevated levels confirm CHF diagnosis and track severity. A low value has high negative predictive value for ruling out CHF.
  • Troponin - elevated in acute decompensation
  • Renal function / Electrolytes - assess for cardiorenal syndrome
  • Thyroid function - screen for reversible cause

7. Management

Non-Pharmacological

  • Salt restriction (< 2g Na/day)
  • Fluid restriction in severe CHF
  • Regular aerobic exercise (physiologic hypertrophy with beneficial capillary density increase - unlike pathologic hypertrophy)
  • Weight monitoring (daily; > 2kg gain in 2 days = seek medical attention)
  • Smoking cessation, alcohol avoidance

Pharmacological - HFrEF (Systolic CHF)

The "Four Pillars" of modern CHF therapy:
1. RAAS Blockade
  • ACE inhibitors (e.g., enalapril, ramipril, lisinopril) - first-line in all patients with LV systolic dysfunction regardless of symptoms. Reduce LV size, improve EF, reduce hospitalizations, and prolong survival. Side effects: dry cough (~5%), angioedema, hyperkalemia, renal dysfunction.
  • ARBs (e.g., valsartan, losartan) - substitute when ACE inhibitor cough or angioedema occurs; similar efficacy.
  • ARNI - Sacubitril/Valsartan (Entresto) - preferred over ACE inhibitor or ARB when tolerated. Sacubitril inhibits neprilysin (which breaks down natriuretic peptides), augmenting beneficial natriuresis and vasodilation. CANNOT be combined with an ACE inhibitor (risk of angioedema from dual bradykinin accumulation).
2. Beta-Blockers (e.g., carvedilol, metoprolol succinate, bisoprolol)
  • Counteract the harmful long-term effects of chronic sympathetic activation
  • Reduce heart rate, prevent arrhythmias, reverse remodeling
  • Must be started low and uptitrated slowly; NEVER start in acute decompensation
  • Cornerstone therapy alongside ARNI/ACE inhibitor
3. Mineralocorticoid Receptor Antagonists (MRA)
  • Spironolactone / Eplerenone - block aldosterone; reduce fibrosis and remodeling; diuretic effect
  • Significant mortality benefit in Class II-IV HF
  • Monitor for hyperkalemia and renal function
4. SGLT2 Inhibitors (e.g., dapagliflozin, empagliflozin)
  • Originally developed for diabetes; now first-line in CHF regardless of diabetes status
  • Reduce hospitalizations and mortality via multiple mechanisms (glycosuria, natriuresis, hemodynamic effects, anti-inflammatory)
Diuretics - Not mortality-reducing, but essential for symptom relief:
  • Loop diuretics (furosemide, torsemide) - first-line for volume overload; reduce preload
  • Thiazides - can be combined for diuretic resistance
Digoxin - Inhibits Na⁺/K⁺-ATPase (the sodium pump) → indirect increase in intracellular Ca²⁺ → positive inotropy. Also slows AV conduction (useful in CHF with AF). Narrow therapeutic window; avoid in renal failure. Does NOT reduce mortality but reduces hospitalizations.
Hydralazine + Isosorbide Dinitrate - Alternative vasodilator combination; especially beneficial in Black patients who cannot tolerate ACE inhibitors/ARBs.
Ivabradine - Inhibits the If "funny current" in the SA node; slows heart rate without affecting contractility. Used when heart rate remains elevated (>70 bpm) despite beta-blocker.
  • Goldman-Cecil Medicine; Katzung's Basic and Clinical Pharmacology, 16th Ed.

Device Therapy

  • Cardiac Resynchronization Therapy (CRT/Biventricular pacing) - for patients with LBBB and EF <35%; synchronizes RV and LV contraction; improves LVEF and reduces mortality
  • Implantable Cardioverter-Defibrillator (ICD) - for primary prevention of sudden cardiac death when EF remains <35% despite optimal medical therapy
  • Ventricular Assist Device (VAD) - mechanical support as bridge to transplant or destination therapy in end-stage HF
  • Heart Transplantation - gold standard for Stage D (refractory) CHF

8. Complications

ComplicationMechanism
Atrial FibrillationLA dilation from elevated filling pressures; prevalence 10% (Class I) to 50% (Class IV)
Sudden Cardiac DeathVentricular arrhythmias from ion channel changes, ischemia, electrolyte disturbances
Cardiorenal SyndromeReduced renal perfusion + venous congestion → worsening renal function
Thromboembolic eventsStasis of blood in dilated chambers; risk of LV mural thrombus, stroke
Cardiac CirrhosisLongstanding severe right-sided CHF → centrizonal hepatic fibrosis
Pulmonary HypertensionChronic elevated pulmonary venous pressure → pulmonary arterial remodeling
Malnutrition / CachexiaBowel edema, poor absorption, increased catabolism
  • Braunwald's Heart Disease; Robbins, Cotran & Kumar Pathologic Basis of Disease

9. Prognosis

CHF carries a significant mortality burden:
  • ~50% of patients with Class IV symptoms die within 1 year
  • Major causes of death: sudden arrhythmic death and progressive pump failure
  • Prognostic markers: LVEF, NYHA class, BNP levels, renal function, serum sodium
  • Modern quadruple therapy (ARNI + beta-blocker + MRA + SGLT2i) has dramatically improved prognosis compared to older regimens

Summary at a Glance

Reduced Cardiac Output
        ↓
↑ Sympathetic / RAAS activation
        ↓
Tachycardia, vasoconstriction, Na+H₂O retention
        ↓
↑ Afterload + ↑ Preload
        ↓
Further pump failure → Remodeling → Apoptosis
        ↓
Pulmonary congestion (Left CHF) + Systemic congestion (Right CHF)
The understanding that CHF is driven by neurohumoral activation (not just reduced pumping) is the basis for modern therapy: blocking the sympathetic system (beta-blockers), RAAS (ACE inhibitors/ARBs/ARNIs/MRAs), and augmenting natriuretic peptides (neprilysin inhibition, SGLT2i) rather than simply strengthening the heart's contractions.

It's ecg changes

Reading File
ECG changes in CHF - this is a visual/clinical topic. Let me search the library and for ECG images in parallel.
Finding Sources
Finding Sources
Searching Images

ECG changes heart failure left bundle branch block

This diagnostic image displays a comparison between two 12-lead electrocardiograms (ECG) labeled A and B. Panel A (Baseline ECG) shows normal sinus rhythm with characteristic features of left bundle branch block (LBBB), including a prolonged QRS duration of 150 ms, wide slurred R waves in leads I and aVL, and deep S waves in leads V1-V3. Panel B (Post-CRT-P ECG) demonstrates the electrical changes following the implantation of a cardiac resynchronization therapy pacemaker. Key features in Panel B include visible pacing artifacts (vertical spikes) preceding the QRS complexes, indicating ventricular pacing. The QRS complex in the post-procedure ECG is slightly narrower (140 ms) compared to baseline, though still wider than normal, and exhibits T-wave inversions discordant with the paced QRS complexes. This comparison highlights the impact of biventricular pacing on ventricular depolarization and repolarization patterns in a patient with heart failure and LBBB.

This diagnostic image displays a comparison between two 12-lead electrocardiograms (ECG) labeled A and B. Panel A (Baseline ECG) shows normal sinus rhythm with characteristic features of left bundle branch block (LBBB), including a prolonged QRS duration of 150 ms, wide slurred R waves in leads I and aVL, and deep S waves in leads V1-V3. Panel B (Post-CRT-P ECG) demonstrates the electrical changes following the implantation of a cardiac resynchronization therapy pacemaker. Key features in Panel B include visible pacing artifacts (vertical spikes) preceding the QRS complexes, indicating ventricular pacing. The QRS complex in the post-procedure ECG is slightly narrower (140 ms) compared to baseline, though still wider than normal, and exhibits T-wave inversions discordant with the paced QRS complexes. This comparison highlights the impact of biventricular pacing on ventricular depolarization and repolarization patterns in a patient with heart failure and LBBB.

This composite diagnostic image features a posterobanterio (PA) chest X-ray and a 12-lead electrocardiogram (ECG) demonstrating cardiovascular complications. Image (A) is a chest radiograph showing significant cardiomegaly with a prominent cardiac silhouette and a cardiothoracic ratio greater than 0.5. There is evidence of bilateral pulmonary congestion, characterized by increased interstitial markings and hazy opacities, particularly in the perihilar regions and lower lung fields, consistent with acute heart failure. Image (B) displays a 12-lead ECG demonstrating a wide QRS complex (exceeding 120 ms) with a morphology characteristic of a complete left bundle branch block (LBBB), including deep S-waves in lead V1 and broad, notched R-waves in the lateral leads. Notably, there is poor R-wave progression across the precordial leads (V1–V4), which can be seen in anteroseptal myocardial injury or dilated cardiomyopathy. The combination of images illustrates clinical findings of drug-induced (osimertinib) cardiotoxicity, highlighting the relationship between structural cardiac changes (dilation/failure) and corresponding electrical conduction abnormalities.

This composite diagnostic image features a posterobanterio (PA) chest X-ray and a 12-lead electrocardiogram (ECG) demonstrating cardiovascular complications. Image (A) is a chest radiograph showing significant cardiomegaly with a prominent cardiac silhouette and a cardiothoracic ratio greater than 0.5. There is evidence of bilateral pulmonary congestion, characterized by increased interstitial markings and hazy opacities, particularly in the perihilar regions and lower lung fields, consistent with acute heart failure. Image (B) displays a 12-lead ECG demonstrating a wide QRS complex (exceeding 120 ms) with a morphology characteristic of a complete left bundle branch block (LBBB), including deep S-waves in lead V1 and broad, notched R-waves in the lateral leads. Notably, there is poor R-wave progression across the precordial leads (V1–V4), which can be seen in anteroseptal myocardial injury or dilated cardiomyopathy. The combination of images illustrates clinical findings of drug-induced (osimertinib) cardiotoxicity, highlighting the relationship between structural cardiac changes (dilation/failure) and corresponding electrical conduction abnormalities.

This diagnostic image is a 12-lead electrocardiogram (ECG) performed at standard placement, demonstrating normal sinus rhythm with findings classic for a complete left bundle branch block (LBBB). The tracing shows a wide QRS complex (QRSD measured at 186 ms) with a leftward axis (QRS axis of -52 degrees). Key morphological features include broad, notched 'M-shaped' R waves in the lateral leads (I, aVL, V5, and V6) and deep, wide S waves in the right precordial leads (V1-V3). There is a concurrent prolongation of the QTc interval (528 ms) and secondary ST-T wave changes, specifically T-wave inversion in the lateral leads, which are expected in the context of altered ventricular depolarization. This ECG is a critical educational example for identifying conduction delays in the setting of heart failure or cardiomyopathies, such as non-compaction cardiomyopathy, where left ventricular dysfunction is often accompanied by significant intraventricular conduction disturbances.

This diagnostic image is a 12-lead electrocardiogram (ECG) performed at standard placement, demonstrating normal sinus rhythm with findings classic for a complete left bundle branch block (LBBB). The tracing shows a wide QRS complex (QRSD measured at 186 ms) with a leftward axis (QRS axis of -52 degrees). Key morphological features include broad, notched 'M-shaped' R waves in the lateral leads (I, aVL, V5, and V6) and deep, wide S waves in the right precordial leads (V1-V3). There is a concurrent prolongation of the QTc interval (528 ms) and secondary ST-T wave changes, specifically T-wave inversion in the lateral leads, which are expected in the context of altered ventricular depolarization. This ECG is a critical educational example for identifying conduction delays in the setting of heart failure or cardiomyopathies, such as non-compaction cardiomyopathy, where left ventricular dysfunction is often accompanied by significant intraventricular conduction disturbances.

A 12-lead electrocardiogram (ECG) demonstrating a sinus rhythm with significant conduction abnormalities and morphological changes. The rhythm strip shows a heart rate of approximately 82 bpm with identifiable P waves and a PR interval of 180 ms. The QRS complex is markedly widened at 154 ms, exhibiting a morphology consistent with Left Bundle Branch Block (LBBB), characterized by deep S waves in leads V1-V3 and broad, tall R waves in the lateral leads V5 and V6. There is evidence of right axis deviation, which is an atypical finding in the setting of standard LBBB and may suggest concomitant right ventricular hypertrophy or lateral wall infarction. Secondary ST-T wave changes are visible, including T-wave inversions in leads V1 through V6. The QTc interval is prolonged at 500 ms. These findings are clinically relevant for assessing acute myocardial ischemia or cardiomyopathy-related conduction delay in the setting of heart failure.

A 12-lead electrocardiogram (ECG) demonstrating a sinus rhythm with significant conduction abnormalities and morphological changes. The rhythm strip shows a heart rate of approximately 82 bpm with identifiable P waves and a PR interval of 180 ms. The QRS complex is markedly widened at 154 ms, exhibiting a morphology consistent with Left Bundle Branch Block (LBBB), characterized by deep S waves in leads V1-V3 and broad, tall R waves in the lateral leads V5 and V6. There is evidence of right axis deviation, which is an atypical finding in the setting of standard LBBB and may suggest concomitant right ventricular hypertrophy or lateral wall infarction. Secondary ST-T wave changes are visible, including T-wave inversions in leads V1 through V6. The QTc interval is prolonged at 500 ms. These findings are clinically relevant for assessing acute myocardial ischemia or cardiomyopathy-related conduction delay in the setting of heart failure.

Good images found. Let me now search more specifically for ECG content from Braunwald's and also for LVH, atrial fibrillation, and other specific ECG changes in CHF.
Finding Sources
Finding Sources
Searching Images

left ventricular hypertrophy ECG voltage criteria

This composite educational graphic illustrates the diagnostic features of Apical Hypertrophic Cardiomyopathy (ApHCM) through electrocardiography (ECG) and Cardiac Magnetic Resonance (CMR) imaging. Panel A shows a 12-lead ECG characterized by high-voltage QRS complexes in the precordial leads, meeting voltage criteria for left ventricular hypertrophy, and striking, giant negative T-wave inversions (deeply symmetric), particularly in leads V2 through V6. Panels B through E present CMR four-chamber views demonstrating the structural manifestations of the disease. Diastolic imaging (B) shows relative thickening of the left ventricular apex (13.5 mm). Systolic imaging (C) depicts apical cavity obliteration, where the hypertrophied myocardium eliminates the distal ventricular space. Panel D identifies a small apical aneurysm, a known complication of localized hypertrophy. Panel E displays Late Gadolinium Enhancement (LGE) at the apex, indicating localized myocardial fibrosis or scarring. Collectively, these images provide a comprehensive clinical overview of ApHCM's electrical and structural pathology.

This composite educational graphic illustrates the diagnostic features of Apical Hypertrophic Cardiomyopathy (ApHCM) through electrocardiography (ECG) and Cardiac Magnetic Resonance (CMR) imaging. Panel A shows a 12-lead ECG characterized by high-voltage QRS complexes in the precordial leads, meeting voltage criteria for left ventricular hypertrophy, and striking, giant negative T-wave inversions (deeply symmetric), particularly in leads V2 through V6. Panels B through E present CMR four-chamber views demonstrating the structural manifestations of the disease. Diastolic imaging (B) shows relative thickening of the left ventricular apex (13.5 mm). Systolic imaging (C) depicts apical cavity obliteration, where the hypertrophied myocardium eliminates the distal ventricular space. Panel D identifies a small apical aneurysm, a known complication of localized hypertrophy. Panel E displays Late Gadolinium Enhancement (LGE) at the apex, indicating localized myocardial fibrosis or scarring. Collectively, these images provide a comprehensive clinical overview of ApHCM's electrical and structural pathology.

This comparative medical illustration presents short-axis Cardiac Magnetic Resonance (CMR) images and corresponding Electrocardiogram (ECG) tracings for two types of Left Ventricular Hypertrophy (LVH). Panel A demonstrates concentric LVH, characterized by a significantly thickened myocardial wall and a reduced left ventricular (LV) end-diastolic cavity diameter (42 mm). The adjacent ECG shows high-voltage R waves in leads V5 and V6 with accompanying ST-segment depression and T-wave inversion, consistent with a left ventricular strain pattern. Panel B illustrates eccentric LVH, featuring a dilated LV cavity (end-diastolic diameter 60 mm) and relatively thinner myocardial walls compared to the concentric model. The corresponding ECG in panel B shows high-voltage R waves but with upright T waves and less pronounced ST-segment changes. The visual comparison highlights the structural differences between pressure-overload (concentric) and volume-overload (eccentric) remodeling and their respective electrophysiological manifestations, facilitating the study of cardiac morphology and ECG-LVH correlation criteria.

This comparative medical illustration presents short-axis Cardiac Magnetic Resonance (CMR) images and corresponding Electrocardiogram (ECG) tracings for two types of Left Ventricular Hypertrophy (LVH). Panel A demonstrates concentric LVH, characterized by a significantly thickened myocardial wall and a reduced left ventricular (LV) end-diastolic cavity diameter (42 mm). The adjacent ECG shows high-voltage R waves in leads V5 and V6 with accompanying ST-segment depression and T-wave inversion, consistent with a left ventricular strain pattern. Panel B illustrates eccentric LVH, featuring a dilated LV cavity (end-diastolic diameter 60 mm) and relatively thinner myocardial walls compared to the concentric model. The corresponding ECG in panel B shows high-voltage R waves but with upright T waves and less pronounced ST-segment changes. The visual comparison highlights the structural differences between pressure-overload (concentric) and volume-overload (eccentric) remodeling and their respective electrophysiological manifestations, facilitating the study of cardiac morphology and ECG-LVH correlation criteria.

This composite figure presents clinical imaging and electrocardiogram (ECG) data for Hypertrophic Cardiomyopathy (HCM) associated with specific genetic variants.

This composite figure presents clinical imaging and electrocardiogram (ECG) data for Hypertrophic Cardiomyopathy (HCM) associated with specific genetic variants.

Good. Let me now read the Harrison's section on LVH ECG criteria and the Fuster/Hurst section on LV dysfunction ECG findings.
Reading File
Reading File
Finding Sources
Let me get the Goldman-Cecil section on LVH repolarization and Harrison's LBBB details, plus fetch key ECG images.
Reading File
Reading File
Loading Image
Excellent - I now have the LBBB diagram URL and an excellent paired CXR + ECG showing heart failure with LBBB. Let me fetch one more key image.
Loading Image
Loading Image
I now have all the content and images needed for a comprehensive answer. Let me compile it.

ECG Changes in Congestive Heart Failure

The ECG in CHF does not have a single pathognomonic pattern. Instead, it reflects the underlying cause of CHF and the structural/electrical consequences of the failing heart. Here is a systematic breakdown of all key ECG changes:

1. Sinus Tachycardia

  • One of the earliest and most consistent ECG findings in CHF
  • Results from compensatory sympathetic activation (increased catecholamines) and withdrawal of parasympathetic tone
  • Heart rate typically 100-120 bpm
  • A resting tachycardia in a CHF patient is a poor prognostic sign

2. Left Ventricular Hypertrophy (LVH)

The most common structural ECG finding in CHF, especially from hypertension, aortic stenosis, or volume overload.
Voltage Criteria for LVH:
CriterionMeasurementThreshold
Sokolow-LyonSV1 + RV5 (or RV6)≥ 35 mm
Cornell voltageSV2 + RaVL≥ 28 mm (men), ≥ 20 mm (women)
Limb leadR aVL alone> 28 mm (men), > 20 mm (women)
Associated ECG features of LVH:
  • "Strain" pattern - ST segment depression with asymmetric T-wave inversion in lateral leads (I, aVL, V5, V6) - these are secondary repolarization abnormalities from the hypertrophied muscle
  • Left axis deviation (LAD)
  • Left atrial enlargement (LAE) - broad, notched P wave in II ["P mitrale"], biphasic P in V1 with wide terminal negative deflection
  • LVH often progresses to incomplete or complete LBBB
LVH ECG: Striking S-wave amplitude in right precordial leads and tall R waves in left precordial leads with repolarization ("strain") abnormalities. SV2 + RaVL = 3.4 mV, satisfying Cornell voltage criteria.
Fig: 12-lead ECG from a 76-year-old hypertensive man showing LVH - tall precordial voltages with lateral ST-T strain pattern. Cornell criteria satisfied. From Goldman-Cecil Medicine.
Comparison of concentric vs. eccentric LVH on CMR and ECG. Concentric LVH shows high-voltage R waves with ST depression/T-wave inversion (strain); eccentric LVH shows high-voltage with upright T waves.
  • Harrison's Principles of Internal Medicine, 22nd Ed.; Goldman-Cecil Medicine

3. Left Bundle Branch Block (LBBB)

LBBB is the most clinically significant ECG change in CHF. It is a marker of one of four underlying conditions: coronary artery disease, hypertensive heart disease, aortic valve disease, and cardiomyopathy - all leading causes of CHF.
Diagnostic criteria for complete LBBB (QRS ≥ 120 ms):
LeadPattern
V1Wide, predominantly negative QS or rS complex
V5, V6, I, aVLBroad, notched (M-shaped) positive R wave (no q wave)
ST-T waveDiscordant - T wave is opposite in polarity to the terminal QRS deflection
Why LBBB matters in CHF:
  • It causes dyssynchronous ventricular contraction - the LV lateral wall contracts late, reducing pump efficiency
  • LBBB with EF ≤ 35% is the primary indication for Cardiac Resynchronization Therapy (CRT/biventricular pacing)
  • New-onset LBBB in a CHF patient = assume ischemic cause until proven otherwise
LBBB ECG pattern diagram: In V1 - wide QS complex; in V6 - broad M-shaped R wave. Note discordant secondary T-wave inversions (arrows). RBBB shown for comparison above.
Fig: Comparison of RBBB vs LBBB patterns in leads V1 and V6. LBBB = wide QS in V1, broad M-shaped R in V6, discordant T inversions. From Harrison's Principles of Internal Medicine.
Chest X-ray and 12-lead ECG in a patient with heart failure and LBBB. CXR shows cardiomegaly with pulmonary congestion. ECG shows wide QRS >120 ms with LBBB morphology, poor R-wave progression, and ST-T changes.
  • Harrison's Principles of Internal Medicine, 22nd Ed.

4. Atrial Fibrillation (AF)

AF is the most common arrhythmia in CHF, with a prevalence rising from ~10% in NYHA Class I to ~50% in Class IV.
ECG Features of AF:
  • Absent P waves - replaced by irregular fibrillatory baseline (f waves), best seen in V1 and II
  • Irregularly irregular RR intervals
  • Narrow QRS (unless aberrant conduction or bundle branch block coexists)
CHF-AF relationship is bidirectional:
  • LA dilation from elevated filling pressures → AF
  • AF with rapid ventricular rate can itself cause cardiomyopathy (tachycardia-induced cardiomyopathy)
  • Loss of atrial kick (atrial systole) contributes ~20-30% of ventricular filling; losing this worsens CHF
  • Braunwald's Heart Disease, A Textbook of Cardiovascular Medicine

5. Non-Specific ST-T Wave Changes

These are very common in CHF and reflect:
  • Subendocardial ischemia from elevated diastolic filling pressures compressing coronary perfusion
  • Digitalis effect - characteristic "reverse tick" or "sagging" ST depression (scoop-shaped), most prominent in V5/V6 and inferior leads. This is a digitalis effect, not toxicity.
  • Electrolyte disturbances from diuretics (hypokalemia → ST depression, flat/inverted T waves, prominent U waves; hypomagnesemia)
  • Secondary changes from bundle branch block

6. QRS Prolongation / Intraventricular Conduction Delay (IVCD)

  • QRS duration > 120 ms (whether from LBBB, RBBB, or non-specific IVCD) indicates dyssynchrony
  • QRS > 150 ms with LBBB morphology = the best predictor of response to CRT
  • Prolonged QRS reflects delayed or disorganized ventricular activation

7. Poor R-Wave Progression (PRWP)

  • R waves fail to grow from V1 → V4 (normally, the R wave gets progressively taller)
  • In CHF from dilated cardiomyopathy or prior anterior MI, extensive myocardial fibrosis causes loss of anterior forces
  • May mimic a "silent" anterior MI on ECG

8. Right Ventricular Hypertrophy (RVH) / Right Heart Strain

Seen in cor pulmonale (right-sided CHF from lung disease) or in left-sided CHF that has led to secondary pulmonary hypertension:
  • Right axis deviation (axis > +90°)
  • Tall R waves in V1 (R > S in V1)
  • Deep S waves in V5/V6
  • ST depression and T-wave inversion in right precordial leads (V1-V4) - "right ventricular strain"
  • P pulmonale - tall, peaked P waves in II > 2.5 mm (right atrial enlargement)
  • S1Q3T3 pattern (if acute right heart strain from pulmonary embolism precipitating CHF)
Note: In emphysema-related cor pulmonale, the classic RVH pattern is often absent; instead, there is slow R-wave progression and low voltage from hyperaeration.
  • Harrison's Principles of Internal Medicine, 22nd Ed.

9. Low Voltage

Defined as: All QRS complexes in limb leads < 5 mm AND in precordial leads < 10 mm.
Causes of low voltage in the context of CHF:
  • Pericardial effusion (especially cardiac tamponade)
  • Dilated cardiomyopathy (fibrosis replaces functional myocardium)
  • Cardiac amyloidosis - a classic pattern of low voltage WITH significant LVH on echo ("voltage-mass discrepancy")
  • Obesity, anasarca (edema increases resistance)
  • Hypothyroidism (a reversible cause of CHF)
CauseKey ECG Feature
Pericardial effusionLow voltage ± electrical alternans
AmyloidosisLow voltage + pseudo-infarct Q waves in inferior/lateral leads
Dilated cardiomyopathyLow voltage + LBBB + poor R-wave progression
  • Goldman-Cecil Medicine

10. Prolonged QTc

  • Commonly seen in CHF patients due to electrolyte disturbances (hypokalemia, hypomagnesemia from diuretics), drug effects (amiodarone, sotalol, digoxin toxicity), and underlying cardiomyopathy
  • QTc > 500 ms significantly increases risk of Torsades de Pointes
  • Important: LBBB itself causes QTc prolongation as a secondary repolarization change - this must be distinguished from primary QT prolongation

11. Ischemic Changes (If Underlying IHD)

Since ischemic heart disease (IHD) is the most common cause of CHF:
  • Q waves - pathologic Q waves (> 40 ms wide, > 25% of R-wave amplitude) indicate prior MI, which caused the CHF
  • ST segment changes - ST elevation in acute decompensation from ACS; ST depression from subendocardial ischemia
  • T-wave inversions - "Wellens syndrome" pattern (symmetric deep inversions in V2-V4) = critical LAD disease

Summary Table - ECG Changes in CHF

ECG FindingUnderlying CauseClinical Significance
Sinus tachycardiaSympathetic activationCompensation, poor prognosis
LVH (voltage + strain)Hypertension, pressure overloadSuggests long-standing CHF cause
LBBBCardiomyopathy, IHDDyssynchrony; CRT candidacy (if EF ≤35%)
AFLA dilation, neurohumoralWorsens CHF; treat rate/rhythm
Poor R-wave progressionAnterior MI, DCM fibrosisSilent prior infarction
Low voltagePericardial effusion, amyloid, DCMIdentifies specific etiology
Right heart strainPulmonary HTN, cor pulmonaleRight-sided CHF
Prolonged QTcElectrolytes, drugsArrhythmia risk
Pathologic Q wavesPrior MIIHD as CHF etiology
Digitalis effectDigoxin therapyDrug effect (≠ toxicity)
Electrical alternansLarge pericardial effusionTamponade risk

Key Clinical Point

The ECG alone cannot diagnose or exclude CHF, but it provides vital clues about etiology and consequences. As stated in Fuster and Hurst's The Heart, the ECG can confirm underlying abnormalities such as ischemia, conduction defects, and chamber enlargement - all of which guide management. Always correlate ECG with BNP/NT-proBNP levels and echocardiography for definitive assessment.
  • Harrison's Principles of Internal Medicine, 22nd Ed.; Goldman-Cecil Medicine; Braunwald's Heart Disease
This is a shared conversation. Sign in to Orris to start your own chat.